Michael Weekes | Clinical Neuroscience | Innovative Research Award

Innovative Research Award

Michael Weekes
Affiliation University Hospitals Birmingham NHS Foundation Trust
Country United Kingdom
Scopus ID 60449334700
Documents 3
Subject Area Clinical Neuroscience
Event World Neuroscientists Awards

Michael Weekes

University Hospitals Birmingham NHS Foundation Trust

The Innovative Research Award recognizes researchers whose scholarly activities contribute to advancing scientific knowledge through original investigation, clinical innovation, and evidence-based practice. Michael Weekes, affiliated with the University Hospitals Birmingham NHS Foundation Trust, has established a research profile within Clinical Neuroscience through peer-reviewed scientific publications indexed in Scopus. His academic contributions reflect engagement in clinically relevant neurological research and multidisciplinary healthcare investigations.[1]

Abstract

Michael Weekes has contributed to Clinical Neuroscience through scholarly publications that support evidence-based clinical practice and neurological healthcare. His published research demonstrates participation in advancing scientific understanding of neurological conditions while contributing to multidisciplinary healthcare literature. Recognition through the Innovative Research Award aligns with measurable scholarly productivity and the potential clinical relevance of his research activities.[1]

Keywords

Clinical Neuroscience, Neurology, Evidence-Based Medicine, Clinical Research, Healthcare Innovation, Neuroscience, Medical Research, Neurological Disorders, Patient Care, Scientific Publications

Introduction

Clinical neuroscience integrates scientific investigation with patient-centered healthcare to improve the diagnosis, treatment, and management of neurological disorders. Researchers working in this discipline contribute to translational knowledge that supports better clinical decision-making and improved healthcare outcomes. Scholarly publications indexed within recognized academic databases provide measurable indicators of research engagement and scientific dissemination.[2]

Research Profile

Michael Weekes is affiliated with the University Hospitals Birmingham NHS Foundation Trust in the United Kingdom. His Scopus author profile records three indexed scholarly publications within Clinical Neuroscience. These publications demonstrate active participation in peer-reviewed scientific communication and contribute to the broader neurological research community.[1]

Research Contributions

  • Participation in peer-reviewed Clinical Neuroscience research.
  • Contribution to evidence-based neurological healthcare literature.
  • Support for multidisciplinary clinical investigations.
  • Promotion of scientific knowledge dissemination through indexed publications.

Publications

The available Scopus profile identifies three peer-reviewed documents attributed to Michael Weekes. Publication records demonstrate academic engagement and provide evidence of contributions to contemporary Clinical Neuroscience research. Detailed bibliographic records are accessible through the official Scopus Author Profile.[1]

Research Impact

Research impact may be evaluated using indicators such as publication output, citation performance, interdisciplinary collaboration, and clinical applicability. While complete citation metrics are not specified within the provided profile, indexed publications demonstrate measurable scholarly activity within internationally recognized scientific databases and support visibility within the research community.[1]

Award Suitability

Based on the available academic information, Michael Weekes demonstrates eligibility for consideration within the Innovative Research Award category through documented scholarly publications, institutional affiliation, and participation in Clinical Neuroscience research. The available evidence supports recognition of scientific contribution while acknowledging that comprehensive assessment should also consider publication quality, citation impact, originality, collaborative achievements, and broader influence on clinical practice.[1]

Conclusion

Michael Weekes has established an emerging scholarly profile through peer-reviewed Clinical Neuroscience publications associated with the University Hospitals Birmingham NHS Foundation Trust. His documented academic activities contribute to evidence-based neurological research and align with the objectives of recognizing innovation, scientific integrity, and continued advancement within the World Neuroscientists Awards program.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Michael Weekes, Author ID 60449334700. Scopus.
    https://www.scopus.com/pages/authors/60449334700
  2. National Institute of Neurological Disorders and Stroke. Clinical neuroscience research overview.
    https://doi.org/10.1038/nrn3241

Shan Ping Yu | Translational Neuroscience | Innovative Research Award

Innovative Research Award

Shan Ping Yu, 
Emory University School of Medicine, Atlanta, Georgia, United States

Shan Ping Yu
Affiliation Emory University School of Medicine
Country United States
Scopus ID 36157350300
Documents 194
Citations 14,194
h-index 62
Subject Area Neuroscience, Stroke Research, Stem Cell Biology, Neurodegeneration, Translational Neuroscience
Event World Neuroscientists Awards
ORCID 0000-0003-1335-1398

Shan Ping Yu, is an internationally recognized neuroscientist and physician-scientist affiliated with the Department of Anesthesiology at Emory University School of Medicine. His research career spans several decades and encompasses fundamental and translational investigations in neuroprotection, stroke biology, stem cell therapeutics, ion channel regulation, neurodegenerative disorders, and cellular signaling mechanisms. Through leadership in academic medicine, editorial service, grant review activities, and mentorship, Yu has contributed substantially to contemporary neuroscience research and regenerative medicine initiatives.[1]

Abstract

This academic article examines the professional achievements and scientific contributions of Shan Ping Yu, MD/PhD, whose multidisciplinary research has significantly influenced the fields of neuroscience, neurodegenerative disease biology, stroke pathology, and regenerative medicine. Yu’s investigations into ion channel signaling, neural cell death mechanisms, stem cell therapeutics, and neuroinflammation have contributed to improved understanding of brain injury and neural repair processes. His leadership roles at Emory University and multiple international scientific organizations reflect sustained engagement in advancing translational neuroscience research. The article further evaluates Yu’s publication record, editorial leadership, peer-review service, mentoring activities, and global academic collaborations in the context of scientific recognition and award suitability.[2]

Keywords

  • Neuroscience
  • Stroke Research
  • Neurodegeneration
  • Stem Cell Therapy
  • Ion Channels
  • Cell Death Mechanisms
  • Regenerative Medicine
  • Brain Injury
  • Translational Neuroscience
  • Neural Repair

Introduction

The advancement of neuroscience and neurodegenerative disease research relies heavily on interdisciplinary approaches integrating molecular biology, pharmacology, stem cell science, and translational medicine. Shan Ping Yu has contributed to these developments through extensive investigations into ischemic brain injury, neuronal cell death, neuroprotection, and stem cell-mediated recovery pathways. His scientific career spans academic appointments at Washington University, the Medical University of South Carolina, and Emory University, where he currently serves as Asa Griggs Candler Endowed Professor with tenure.[1]

Yu’s work has also emphasized the clinical relevance of molecular neuroscience discoveries, particularly in relation to stroke, traumatic brain injury, and Alzheimer’s disease research. His studies on ion channels and neuroinflammation have contributed to broader understanding of neuronal survival and regenerative signaling mechanisms.[3]

Research Profile

Shan Ping Yu obtained his MD and MS degrees from the Capital Institute of Medicine in Beijing, China, followed by a PhD from the State University of New York at Stony Brook. His postdoctoral training at the Howard Hughes Medical Institute further strengthened his expertise in neurobiology and cellular signaling mechanisms. Yu later established an internationally recognized research program focused on ischemic brain injury and neuroregeneration.[4]

At Emory University School of Medicine, Yu has led multidisciplinary projects examining molecular pathways involved in neuronal injury and neural repair. His research integrates experimental neuroscience with translational therapeutic development, particularly in stem cell-based interventions and neuroprotective pharmacology.[5]

Research Contributions

Yu has contributed substantially to the understanding of neuronal apoptosis, necrosis, oxidative stress signaling, and ionic dysregulation during cerebral ischemia. His investigations into potassium and calcium channel modulation in neuronal injury have influenced experimental stroke therapeutics and neuroprotective strategies.[5]

Another major area of contribution involves stem cell therapy for neurological disorders. Yu’s collaborative studies explored mechanisms by which stem cells facilitate neural repair and functional recovery following stroke and traumatic brain injury. These investigations have informed broader regenerative medicine strategies aimed at restoring neural circuitry after injury.[4]

Publications

Yu’s publication portfolio includes numerous peer-reviewed articles in neuroscience, pharmacology, neurochemistry, and regenerative medicine journals. His work has appeared in internationally recognized journals including Stroke, Journal of Neuroscience, PNAS, Cell Death & Disease, and Translational Stroke Research.[2]

Research Impact

Yu’s scientific impact extends across neuroscience, regenerative medicine, and translational stroke research communities. His participation in NIH, NSF, VA, and international grant review panels demonstrates recognition as an authority in neurobiology and neurological disease research. He has also supervised postdoctoral fellows and junior investigators who subsequently obtained faculty appointments and research leadership positions internationally.[1]

His mentorship activities and commitment to diversity and inclusion in STEM education have contributed to career advancement opportunities for minority scholars and international researchers. Yu’s involvement with the PATHs AGEP Alliance and mentorship of early-career investigators highlights sustained contributions to academic workforce development.[2]

Award Suitability

Shan Ping Yu’s research career demonstrates sustained excellence in neuroscience and neurodegenerative disease investigation. His extensive publication record, international scientific collaborations, editorial leadership, conference organization, grant review participation, and mentoring contributions collectively support recognition within advanced scientific award categories. His work has influenced both experimental neuroscience research and translational therapeutic development in stroke and neurodegeneration.[2]

The breadth of Yu’s contributions across academia, research administration, and scientific mentorship aligns strongly with criteria commonly associated with lifetime achievement, excellence in neuroscience research, and translational medicine awards.[3]

Conclusion

Shan Ping Yu, MD/PhD, has established a distinguished international reputation in neuroscience and regenerative medicine through decades of scholarly achievement, translational research, and scientific leadership. His work in neuroprotection, stem cell therapy, neurodegeneration, and stroke biology has contributed to improved understanding of neurological disease mechanisms and therapeutic strategies. Through mentorship, peer-review service, conference organization, and editorial activities, Yu has also strengthened global neuroscience research networks and academic training initiatives.[4]

References

  1. Emory University School of Medicine. (2025). Faculty Curriculum Vitae: Shan Ping Yu, MD/PhD.
  2. Elsevier. (n.d.). Scopus author details: Shan Ping Yu, Author ID 36157350300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=36157350300
  3. ScienceDaily. (2021). Alternative model of Alzheimer’s emphasizes different mechanisms leading to neurodegeneration.
  4. State University of New York at Stony Brook. Postdoctoral and doctoral research records related to neuroscience training.
  5. Emory University School of Medicine. Department of Anesthesiology faculty profile and research overview.

Xufeng Huang | Neuroscience of Obesity and Schizophrenia | Neuroscience Academic Excellence Award

Prof. Dr. Xufeng Huang | Neuroscience of Obesity and Schizophrenia | Neuroscience Academic Excellence Award

University of Wollongong | Australia

Professor Xufeng Huang is an internationally recognised molecular neuroscientist whose research integrates brain biology, metabolism, psychopharmacology, and nutritional science to address major public health challenges. His work has elucidated central molecular mechanisms of diet-induced obesity, including leptin resistance, neural injury, and cognitive decline, and translated these discoveries into preventive and therapeutic strategies. He has led pioneering research on antipsychotic-induced metabolic disorders in schizophrenia, identifying key neurotransmitter and receptor pathways and advancing safer pharmacological and adjunctive interventions. Professor Huang has also driven innovation in functional nutrition, notably the discovery and clinical validation of β-glucan as an effective dietary fibre for metabolic syndrome control, influencing dietary guidelines and policy. With extensive leadership of NHMRC-funded programs and international collaborations, his research spans mechanistic discovery, animal and human studies, and clinical translation. His contributions have shaped evidence-based interventions in brain health, obesity, metabolic disease, and severe mental illness, with sustained impact on clinical practice, policy development, and translational research across Australia and internationally.

Citation Metrics (Scopus)

16000
10000
6000
1000
0

Citations
14,714

Documents
349

h-index
66

Citations

Documents

h-index

View Scopus Profile View ORCID Profile View Google Scholar Profile

Featured Publications

Development of high fat diet-induced obesity and leptin resistance in C57Bl/6J mice
– S Lin, TC Thomas, LH Storlien, XF Huang, International Journal of Obesity, 2000

Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression
– H Wang, LH Storlien, XF Huang, American Journal of Physiology–Endocrinology and Metabolism, 2002

Selective antagonist [3H] SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia
– K Zavitsanou, T Garrick, XF Huang, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2004

Molecular evidence of N-methyl-D-aspartate receptor hypofunction in schizophrenia
– CS Weickert, SJ Fung et al., Molecular Psychiatry, 2013